Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Extragonadal Germ Cell Tumors Clinical Presentation

  • Author: Kush Sachdeva, MD; Chief Editor: Jules E Harris, MD, FACP, FRCPC  more...
 
Updated: Apr 16, 2015
 

History

Symptoms vary depending on the site and the size of the tumor. Those arising in nonvital organs can reach large sizes before becoming symptomatic, but small tumors may result in significant symptoms if they obstruct, compress, or rupture into important structures.[9]

Mediastinal germ cell tumors

The mediastinum is the most common site of extragonadal germ cell tumors. Mediastinal germ cell tumors account for only 2-5% of all germinal tumors, but they constitute 50-70% of all extragonadal tumors. Mediastinal germ cell tumors account for 1-15% of adult anterior mediastinal tumors. Mature teratomas represent 60-70% of mediastinal germ cell tumors. Malignant mediastinal germ cell tumors (30-40%) are divided between seminomas (40%) and nonseminomatous germ cell tumors (60%). Although 90-100% of malignant germ cell tumors are symptomatic, only 50% of teratomas produce symptoms. Nonseminomatous mediastinal germ cell tumors (NS-MGCTs) are faster growing and metastasize earlier than mediastinal seminomas.

Although their incidence peaks in the third decade, several cases have been reported in patients older than 60 years.

Patients with mediastinal germ cell tumors may present with the following (in decreasing order):

  • Chest pain (39%)
  • Dyspnea (29%)
  • Cough (22%)
  • Weight loss (19%)
  • Superior vena cava syndrome (12%)
  • Nausea (6%)
  • Fever (6%)
  • Postobstructive pneumonia
  • Weight loss
  • Night sweats
  • Dysphagia
  • Shoulder or arm pain
  • Vocal cord paralysis
  • Hoarseness

In one third of patients the anterior mediastinal mass is an incidental finding of a routine chest radiograph (in most of these cases, a benign tumor is found).

Metastases to locoregional lymph nodes or to distant sites, such as the lungs, liver, or bone, may be present in 20-50% of cases on presentation. Distant metastases are seen only in malignant mediastinal germ cell tumors.

Mature teratoma rupture, teratoma with malignant transformation, and hematologic malignancies may complicate mediastinal germ cell tumors (see Complications).

Retroperitoneal germ cell tumors

The second most common site of extragonadal germ cell tumors (30-40%), after the mediastinum, is the retroperitoneum. Retroperitoneal germ cell tumors (RGCTs) represent 10% of all malignant primary retroperitoneal tumors.

Often patients with retroperitoneal germ cell tumors present late, after their tumors have reached large dimensions. Presenting symptoms are abdominal mass with or without pain, backache, and weight loss. Loss of ejaculation was reported in one case.

Intracranial germ cell tumors

Very rare tumors of the adolescent and young adult, intracranial germ cell tumors (ICGCTs) are localized preferentially to the pineal and suprasellar regions. However, other midline structures can be involved. Although seminomas (60% of intracranial germ cell tumors) have a predilection for the suprasellar region, embryonal carcinomas, yolk-sac tumors, and choriocarcinomas mainly occur in the pineal region.

Pineal tumors present with headache, nausea, and vomiting because of increased intracranial pressure; they require early ventriculoperitoneal (VP) shunting. Deterioration of intellectual functions, gait abnormalities with frequent falls, and sphincteric incontinence are common. Choreic movements and ataxia of the limbs with spastic weakness appear in later stages of Parinaud syndrome.

n suprasellar tumors, precocious pseudopuberty, diabetes insipidus with or without anterior pituitary dysfunctions (eg, adrenocorticotropic hormone [ACTH] deficiency), central hypothyroidism, growth hormone (GH) deficiency, and hypogonadism may be seen. Decreased visual acuity, visual field defect, diplopia, obesity, psychosis, and obsessive-compulsive symptoms have also been reported.

A case of primary spinal seminoma has been reported in a patient with Klinefelter syndrome.[10]

Sacrococcygeal germ cell tumors

In the literature to date, 17 cases have been reported. Pain and bowel habit change are the main symptoms. Severe arthropathy of peripheral joints and evidence of hypertrophic osteoarthropathy were reported in one case.

Extragonadal germ cell cancer syndrome

Midline fast-growing tumors (eg, of the mediastinum, retroperitoneum) occur in young males. Histologically, these tumors are poorly differentiated carcinomas with atypical features.

The germ cell origin of these tumors is suggested by the typical abnormalities of chromosome 12 and the elevation of beta human chorionic gonadotropin (bhCG) and/or alpha-fetoprotein (AFP).

Next

Physical

Complete physical examination is required.

  • Mediastinal germ cell tumors (MGCTs) may be silent. Dullness caused by atelectasis or pleural effusion and localized wheezes because of airway compression may be present.
  • A large abdominal mass may be palpated in retroperitoneal germ cell tumors (RGCTs).
  • In suprasellar intracranial germ cell tumors (ICGCTs), decreased visual acuity and visual field defects, obesity, or signs of endocrine deficiencies may be present.
  • In pineal tumors, Parinaud syndrome (ie, paralysis of conjugate upward gaze, slightly dilated pupils that react on accommodation but not to light, with a lesion at the level of the superior colliculi) can be present. Gait abnormalities, papilledema, and grasp reflex because of hydrocephalus are present variably. Plantar reflexes are sometimes extensor.
Previous
Next

Causes

See Pathophysiology.

Previous
 
 
Contributor Information and Disclosures
Author

Kush Sachdeva, MD Southern Oncology and Hematology Associates, South Jersey Healthcare, Fox Chase Cancer Center Partner

Disclosure: Nothing to disclose.

Coauthor(s)

Brendan Curti, MD Director, Genitourinary Oncology Research, Robert W Franz Cancer Research Center, Earle A Chiles Research Institute, Providence Cancer Center

Brendan Curti, MD is a member of the following medical societies: American College of Physicians, American Society of Clinical Oncology, Oregon Medical Association, Society for Immunotherapy of Cancer

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Prometheus Pharmaceuticals<br/>Received research grant from: Prometheus Pharmaceuticals.

Issam Makhoul, MD Associate Professor, Department of Medicine, Division of Hematology/Oncology, University of Arkansas for Medical Sciences

Issam Makhoul, MD is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology

Disclosure: Nothing to disclose.

Bagi RP Jana, MD Associate Professor of Medicine (Genitourinary Oncology), Division of Hematology and Oncology, University of Texas Medical Branch

Bagi RP Jana, MD is a member of the following medical societies: American Cancer Society, American Medical Association, SWOG, American Society of Clinical Oncology

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Jules E Harris, MD, FACP, FRCPC Clinical Professor of Medicine, Section of Hematology/Oncology, University of Arizona College of Medicine, Arizona Cancer Center

Jules E Harris, MD, FACP, FRCPC is a member of the following medical societies: American Association for the Advancement of Science, American Society of Hematology, Central Society for Clinical and Translational Research, American Society of Clinical Oncology

Disclosure: Nothing to disclose.

Additional Contributors

Robert C Shepard, MD, FACP Associate Professor of Medicine in Hematology and Oncology at University of North Carolina at Chapel Hill; Vice President of Scientific Affairs, Therapeutic Expertise, Oncology, at PRA International

Robert C Shepard, MD, FACP is a member of the following medical societies: American Association for Cancer Research, American Association for Physician Leadership, European Society for Medical Oncology, Association of Clinical Research Professionals, American Federation for Clinical Research, Eastern Cooperative Oncology Group, Society for Immunotherapy of Cancer, American Medical Informatics Association, American College of Physicians, American Federation for Medical Research, American Medical Association, American Society of Hematology, Massachusetts Medical Society

Disclosure: Nothing to disclose.

References
  1. Hasle H, Mellemgaard A, Nielsen J, et al. Cancer incidence in men with Klinefelter syndrome. Br J Cancer. 1995 Feb. 71(2):416-20. [Medline].

  2. Hasle H, Jacobsen BB, Asschenfeldt P, et al. Mediastinal germ cell tumour associated with Klinefelter syndrome. A report of case and review of the literature. Eur J Pediatr. 1992 Oct. 151(10):735-9. [Medline].

  3. Bosl GJ, Ilson DH, Rodriguez E, et al. Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J Natl Cancer Inst. 1994 Mar 2. 86(5):349-55. [Medline].

  4. Hartmann JT, Nichols CR, Droz JP, et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst. 2000 Jan 5. 92(1):54-61. [Medline].

  5. Iwato M, Tachibana O, Tohma Y, et al. Alterations of the INK4a/ARF locus in human intracranial germ cell tumors. Cancer Res. 2000 Apr 15. 60(8):2113-5. [Medline].

  6. Dueland S, Stenwig AE, Heilo A, et al. Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94. Br J Cancer. 1998. 77(2):329-35. [Medline].

  7. Takeda S, Miyoshi S, Ohta M, et al. Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution. Cancer. 2003 Jan 15. 97(2):367-76. [Medline].

  8. Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A. Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol. 2013 Aug. 37(4):370-3. [Medline].

  9. Albany C, Einhorn LH. Extragonadal germ cell tumors: clinical presentation and management. Curr Opin Oncol. 2013 May. 25(3):261-5. [Medline].

  10. Ganslandt O, Buchfelder M, Grabenbauer GG. Primary spinal germinoma in a patient with concomitant Klinefelter's syndrome. Br J Neurosurg. 2000 Jun. 14(3):252-5. [Medline].

  11. Albers P, Bender H, Yilmaz H, et al. Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors. Urology. 1999 Apr. 53(4):808-11. [Medline].

  12. Cremerius U, Effert PJ, Adam G, et al. FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med. 1998 May. 39(5):815-22. [Medline].

  13. Stephens AW, Gonin R, Hutchins GD, et al. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol. 1996 May. 14(5):1637-41. [Medline].

  14. De Santis M, Becherer A, Bokemeyer C, et al. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol. 2004 Mar 15. 22(6):1034-9. [Medline].

  15. Womeldorph CM, Zalupski MM, Knoepp SM, Soltani M, Elmunzer BJ. Retroperitoneal germ cell tumor diagnosed by endoscopic ultrasound-guided fine needle aspiration. World J Gastrointest Oncol. 2010 Dec 15. 2(12):443-5. [Medline]. [Full Text].

  16. Cao D, Liu A, Wang F, Allan RW, Mei K, Peng Y, et al. RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases. Mod Pathol. 2011 Feb. 24(2):288-96. [Medline].

  17. Fizazi K, Culine S, Droz JP, et al. Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy. J Clin Oncol. 1998 Feb. 16(2):725-32. [Medline].

  18. Samuels ML, Johnson DE, Holoye PY, et al. Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy. JAMA. 1976 Mar 15. 235(11):1117-20. [Medline].

  19. Walsh GL, Taylor GD, Nesbitt JC, et al. Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors. Ann Thorac Surg. 2000 Feb. 69(2):337-43; discussion 343-4. [Medline].

  20. Saxman SB, Nichols CR, Einhorn LH. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience. J Clin Oncol. 1994 Jul. 12(7):1390-3. [Medline].

  21. Calaminus G, Bamberg M, Baranzelli MC, et al. Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics. 1994 Feb. 25(1):26-32. [Medline].

  22. Balmaceda C, Heller G, Rosenblum M, et al. Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol. 1996 Nov. 14(11):2908-15. [Medline].

  23. Pectasides D, Aravantinos G, Visvikis A, et al. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience. Oncology. 1999 Jul. 57(1):1-9. [Medline].

  24. Nichols CR, Fox EP. Extragonadal and pediatric germ cell tumors. Hematol Oncol Clin North Am. 1991 Dec. 5(6):1189-209. [Medline].

  25. Andre F, Fizazi K, Culine S, et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer. 2000 Jul. 36(11):1389-94. [Medline].

  26. Gunes S, Varon J, Walsh G. Mediastinal teratoma presenting as massive hemoptysis in an adult. J Emerg Med. 1997 May-Jun. 15(3):313-6. [Medline].

  27. Weijl NI, Rutten MF, Zwinderman AH, et al. Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. J Clin Oncol. 2000 May. 18(10):2169-78. [Medline].

  28. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor- based staging system for metastatic germ cell cancers. J Clin Oncol. 1997 Feb. 15(2):594-603. [Medline].

  29. Ganjoo KN, Rieger KM, Kesler KA, et al. Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. Cancer. 2000 Mar 1. 88(5):1051-6. [Medline].

  30. Abeloff MD, Armitage JO, Niederhuber J, et al. Clinical Oncology. 4nd ed. New York: Churchill Livingstone; 2008.

  31. Adebonojo SA, Nicola ML. Teratoid tumors of the mediastinum. Am Surg. 1976 May. 42(5):361-5. [Medline].

  32. Arai K, Ohta S, Suzuki M, et al. Primary immature mediastinal teratoma in adulthood. Eur J Surg Oncol. 1997 Feb. 23(1):64-7. [Medline].

  33. Baranzelli MC, Patte C, Bouffet E, et al. Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer. 1997 Nov 1. 80(9):1792-7. [Medline].

  34. Bokemeyer C, Droz JP, Horwich A, et al. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer. 2001 Apr 1. 91(7):1394-401. [Medline].

  35. Bokemeyer C, Nichols CR, Droz JP, et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J Clin Oncol. 2002 Apr 1. 20(7):1864-73. [Medline].

  36. Broun ER, Nichols CR, Einhorn LH, et al. Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors. Cancer. 1991 Oct 1. 68(7):1513-5. [Medline].

  37. Böhle A, Studer UE, Sonntag RW, et al. Primary or secondary extragonadal germ cell tumors?. J Urol. 1986 May. 135(5):939-43. [Medline].

  38. Chaganti RS, Houldsworth J. Genetics and biology of adult human male germ cell tumors. Cancer Res. 2000 Mar 15. 60(6):1475-82. [Medline].

  39. Chaganti RS, Rodriguez E, Mathew S. Origin of adult male mediastinal germ-cell tumours. Lancet. 1994 May 7. 343(8906):1130-2. [Medline].

  40. Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer. 2004 Nov 1. 101(9):2006-10. [Medline].

  41. Christmas TJ, Doherty AP, Rustin GJ, et al. Primary retroperitoneal germ cell tumours: excision via a thoracoabdominal extraperitoneal approach. Br J Surg. 1997 Jul. 84(7):1022-5. [Medline].

  42. Comiter CV, Renshaw AA, Benson CB, et al. Burned-out primary testicular cancer: sonographic and pathological characteristics. J Urol. 1996 Jul. 156(1):85-8. [Medline].

  43. Crossen JR, Garwood D, Glatstein E, et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol. 1994 Mar. 12(3):627-42. [Medline].

  44. Daugaard G, Rorth M, von der Maase H, et al. Management of extragonadal germ-cell tumors and the significance of bilateral testicular biopsies. Ann Oncol. 1992 Apr. 3(4):283-9. [Medline].

  45. Davis RD Jr, Oldham HN Jr, Sabiston DC Jr. Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg. 1987 Sep. 44(3):229-37. [Medline].

  46. DeVita VT, Lawrence T,S Rosenberg SA, eds. Cancer, Principles and Practice of Oncology. 8th ed. Philadelphia: Lippincott, Williams & Wilkins; 2008.

  47. Donadio AC, Motzer RJ, Bajorin DF, et al. Chemotherapy for teratoma with malignant transformation. J Clin Oncol. 2003 Dec 1. 21(23):4285-91. [Medline].

  48. Droz JP, Horwich A. Extragonadal Germ Cell Tumors. Comprehensive Textbook of Genitourinary Oncology, Vogelzang, NJ, Scardino, PT, Shipley, WU, Doffey, DS (Eds). Second Edition. New York: Lippincott Williams and Wilkins; 2005.

  49. Duchesne GM, Stenning SP, Aass N, et al. Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party. Eur J Cancer. 1997 May. 33(6):829-35. [Medline].

  50. Duffner PK, Cohen ME, Thomas PR, et al. The long-term effects of cranial irradiation on the central nervous system. Cancer. 1985 Oct 1. 56(7 Suppl):1841-6. [Medline].

  51. Dulmet EM, Macchiarini P, Suc B, et al. Germ cell tumors of the mediastinum. A 30-year experience. Cancer. 1993 Sep 15. 72(6):1894-901. [Medline].

  52. Einhorn LH, Williams SD, Loehrer PJ, et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol. 1989 Mar. 7(3):387-91. [Medline].

  53. Feo CF, Chironi G, Porcu A, et al. Videothoracoscopic removal of a mediastinal teratoma. Am Surg. 1997 May. 63(5):459-61. [Medline].

  54. Glenn OA, Barkovich AJ. Intracranial germ cell tumors: a comprehensive review of proposed embryologic derivation. Pediatr Neurosurg. 1996. 24(5):242-51. [Medline].

  55. Gordon MS, Battiato LA, Finch D, et al. Dramatic response of teratoma-associated non--germ-cell cancer with all-trans retinoic acid in a patient with nonseminomatous germ cell tumor. Am J Clin Oncol. 2001 Jun. 24(3):269-71. [Medline].

  56. Hailemariam S, Engeler DS, Bannwart F, et al. Primary mediastinal germ cell tumor with intratubular germ cell neoplasia of the testis--further support for germ cell origin of these tumors: a case report. Cancer. 1997 Mar 1. 79(5):1031-6. [Medline].

  57. Hainsworth JD, Greco FA. Extragonadal germ cell tumors and unrecognized germ cell tumors. Semin Oncol. 1992 Apr. 19(2):119-27. [Medline].

  58. Hainsworth JD, Greco FA. Poorly differentiated carcinoma and germ cell tumors. Hematol Oncol Clin North Am. 1991 Dec. 5(6):1223-31. [Medline].

  59. Hartmann JT, Einhorn L, Nichols CR, et al. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis. J Clin Oncol. 2001 Mar 15. 19(6):1641-8. [Medline].

  60. Hartmann JT, Fossa SD, Nichols CR, et al. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Natl Cancer Inst. 2001 Nov 21. 93(22):1733-8. [Medline].

  61. Hartmann JT, Nichols CR, Droz JP, et al. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. Ann Oncol. 2002 Jul. 13(7):1017-28. [Medline].

  62. Hartmann JT, Nichols CR, Droz JP, et al. The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors. Cancer. 2000 Jun 1. 88(11):2629-35. [Medline].

  63. Heinonen K, Rao PN, Slack JL, et al. Isochromosome 12p in two cases of acute myeloid leukaemia without evidence of germ cell tumour. Br J Haematol. 1996 Jun. 93(3):677-80. [Medline].

  64. Hidalgo M, Paz-Ares L, Rivera F, et al. Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy. Ann Oncol. 1997 Jun. 8(6):555-9. [Medline].

  65. Hooda BS, Finlay JL. Recent advances in the diagnosis and treatment of central nervous system germ-cell tumours. Curr Opin Neurol. 1999 Dec. 12(6):693-6. [Medline].

  66. Horton Z, Schlatter M, Schultz S. Pediatric germ cell tumors. Surg Oncol. 2007 Nov. 16(3):205-13. [Medline].

  67. Horwich A, Paluchowska B, Norman A, et al. Residual mass following chemotherapy of seminoma. Ann Oncol. 1997 Jan. 8(1):37-40. [Medline].

  68. Iczkowski KA, Butler SL, Shanks JH, et al. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors. Hum Pathol. 2008 Feb. 39(2):275-81. [Medline].

  69. Jacob R, Ramadas K, Jyothirmayi R, et al. Extragonadal germ-cell tumors: a ten-year experience. Am J Clin Oncol. 1998 Apr. 21(2):198-202. [Medline].

  70. Knapp RH, Hurt RD, Payne WS, et al. Malignant germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg. 1985 Jan. 89(1):82-9. [Medline].

  71. Knappe UJ, Bentele K, Horstmann M, et al. Treatment and long-term outcome of pineal nongerminomatous germ cell tumors. Pediatr Neurosurg. 1998 May. 28(5):241-5. [Medline].

  72. Kumano M, Miyake H, Hara I, et al. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors. Int J Urol. 2007 Apr. 14(4):336-8. [Medline].

  73. Ladanyi M, Samaniego F, Reuter VE, et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst. 1990 Feb 7. 82(3):221-7. [Medline].

  74. Lewis BD, Hurt RD, Payne WS, et al. Benign teratomas of the mediastinum. J Thorac Cardiovasc Surg. 1983 Nov. 86(5):727-31. [Medline].

  75. Marina N, London WB, Frazier AL, et al. Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study. J Clin Oncol. 2006 Jun 1. 24(16):2544-8. [Medline].

  76. McAleer JJ, Nicholls J, Horwich A. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?. Eur J Cancer. 1992. 28A(4-5):825-8. [Medline].

  77. McKenney JK, Heerema-McKenney A, Rouse RV. Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations. Adv Anat Pathol. 2007 Mar. 14(2):69-92. [Medline].

  78. Medical Economics Staff. Physician Desk Reference. 54th ed. Medical Economics Company; 2000.

  79. Merchant TE, Sherwood SH, Mulhern RK, et al. CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2000 Mar 15. 46(5):1171-6. [Medline].

  80. Moeller KH, Rosado-de-Christenson ML, Templeton PA. Mediastinal mature teratoma: imaging features. AJR Am J Roentgenol. 1997 Oct. 169(4):985-90. [Medline].

  81. Moran CA, Suster S. Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging. Cancer. 1997 Aug 15. 80(4):681-90. [Medline].

  82. Moran CA, Suster S, Koss MN. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases. Cancer. 1997 Aug 15. 80(4):699-707. [Medline].

  83. Moran CA, Suster S, Przygodzki RM, et al. Primary germ cell tumors of the mediastinum: II. Mediastinal seminomas--a clinicopathologic and immunohistochemical study of 120 cases. Cancer. 1997 Aug 15. 80(4):691-8. [Medline].

  84. Mordecai D, Shaw RJ, Fisher PG, et al. Case study: suprasellar germinoma presenting with psychotic and obsessive-compulsive symptoms. J Am Acad Child Adolesc Psychiatry. 2000 Jan. 39(1):116-9. [Medline].

  85. Motzer R, Bosl G, Heelan R, et al. Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol. 1987 Jul. 5(7):1064-70. [Medline].

  86. Motzer RJ, Amsterdam A, Prieto V, et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol. 1998 Jan. 159(1):133-8. [Medline].

  87. Motzer RJ, Rodriguez E, Reuter VE, et al. Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. J Natl Cancer Inst. 1991 Mar 6. 83(5):341-6. [Medline].

  88. Motzer RJ, Rodriguez E, Reuter VE, et al. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol. 1995 Jan. 13(1):274-82. [Medline].

  89. Nichols CR, Roth BJ, Heerema N, et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med. 1990 May 17. 322(20):1425-9. [Medline].

  90. Oosterhuis JW, Stoop H, Honecker F, et al. Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl. 2007 Aug. 30(4):256-63; discussion 263-4. [Medline].

  91. Orazi A, Neiman RS, Ulbright TM, et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer. 1993 Jun 15. 71(12):3873-81. [Medline].

  92. Parada D, Pena KB, Moreira O, et al. Extragonadal retroperitoneal germ cell tumor: primary versus metastases?. Arch Esp Urol. 2007 Jul-Aug. 60(6):713-9. [Medline].

  93. Pectasides D, Valavanis C, Nikolaou M, et al. Molecular markers in extragonadal germ cell tumours: a matched case-control study. Histopathology. 2007 Feb. 50(3):394-6. [Medline].

  94. Perry MC, ed. The Chemotherapy Source Book. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.

  95. Polansky SM, Barwick KW, Ravin CE. Primary mediastinal seminoma. AJR Am J Roentgenol. 1979 Jan. 132(1):17-21. [Medline].

  96. Puc HS, Heelan R, Mazumdar M, et al. Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol. 1996 Feb. 14(2):454-60. [Medline].

  97. Rescorla FJ. Pediatric germ cell tumors. Semin Surg Oncol. 1999 Mar. 16(2):144-58. [Medline].

  98. Richardson RL, Schoumacher RA, Fer MF, et al. The unrecognized extragonadal germ cell cancer syndrome. Ann Intern Med. 1981 Feb. 94(2):181-6. [Medline].

  99. Rothman J, Greenberg RE, Jaffe WI. Nonseminomatous germ cell tumor of the testis 9 years after a germ cell tumor of the pineal gland: case report and review of the literature. Can J Urol. 2008 Jun. 15(3):4122-4. [Medline].

  100. Sawamura Y, Ikeda JL, Tada M, et al. Salvage therapy for recurrent germinomas in the central nervous system. Br J Neurosurg. 1999 Aug. 13(4):376-81. [Medline].

  101. Schmoll HJ, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol. 2004 Sep. 15(9):1377-99. [Medline].

  102. Schneider BP, Kesler KA, Brooks JA, et al. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer. J Clin Oncol. 2004 Apr 1. 22(7):1195-200. [Medline].

  103. Schultz SM, Einhorn LH, Conces DJ Jr, et al. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol. 1989 Oct. 7(10):1497-503. [Medline].

  104. Shivdasani, RA,, Kantoff, PW. Extragonadal germ cell tumors. Raghavan, D, Scher, HI, Leibel, SA, Lange, P (Eds). Principles and Practice of Genitourinary Oncology. Lippincott-Raven: Philadelphia; 1997.

  105. Uchiyama M, Kantoff PW, Kaplan WD. Gallium-67-citrate imaging in extragonadal and gonadal seminomas: relationship to radiologic findings. J Nucl Med. 1994 Oct. 35(10):1624-30. [Medline].

  106. Vuky J, Bains M, Bacik J, et al. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum. J Clin Oncol. 2001 Feb 1. 19(3):682-8. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.